These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6330174

  • 1. Pharmacology and inotropic potential of forskolin in the human heart.
    Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W.
    J Clin Invest; 1984 Jul; 74(1):212-23. PubMed ID: 6330174
    [Abstract] [Full Text] [Related]

  • 2. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.
    Calderone A, Bouvier M, Li K, Juneau C, de Champlain J, Rouleau JL.
    Circ Res; 1991 Aug; 69(2):332-43. PubMed ID: 1650296
    [Abstract] [Full Text] [Related]

  • 3. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
    Fan TH, Liang CS, Kawashima S, Banerjee SP.
    Eur J Pharmacol; 1987 Aug 11; 140(2):123-32. PubMed ID: 2822436
    [Abstract] [Full Text] [Related]

  • 4. The positive inotropic-acting forskolin, a potent adenylate cyclase activator.
    Metzger H, Lindner E.
    Arzneimittelforschung; 1981 Aug 11; 31(8):1248-50. PubMed ID: 7197529
    [Abstract] [Full Text] [Related]

  • 5. Beta-adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass.
    Dupuis JY, Li K, Calderone A, Gosselin H, Yang XP, Anand-Srivastava MB, Teijeira J, Rouleau JL.
    Cardiovasc Res; 1997 Nov 11; 36(2):223-35. PubMed ID: 9463634
    [Abstract] [Full Text] [Related]

  • 6. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
    Böhm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E.
    Eur Heart J; 1988 Aug 11; 9(8):844-52. PubMed ID: 2460351
    [Abstract] [Full Text] [Related]

  • 7. Neurally mediated cardiac effects of forskolin in conscious dogs.
    Iwase M, Ishikawa Y, Shen YT, Shannon RP, Sato N, Ganguly PK, Eki T, Vatner DF, Vatner SF.
    Am J Physiol; 1996 Oct 11; 271(4 Pt 2):H1473-82. PubMed ID: 8897942
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine.
    Yoneyama M, Sugiyama A, Satoh Y, Takahara A, Nakamura Y, Hashimoto K.
    Circ J; 2002 Dec 11; 66(12):1150-4. PubMed ID: 12499623
    [Abstract] [Full Text] [Related]

  • 9. Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.
    Hussain RI, Afzal F, Mørk HK, Aronsen JM, Sjaastad I, Osnes JB, Skomedal T, Levy FO, Krobert KA.
    Br J Pharmacol; 2011 Feb 11; 162(4):908-16. PubMed ID: 21039419
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig.
    Waldeck B, Widmark E.
    Eur J Pharmacol; 1985 Jun 19; 112(3):349-53. PubMed ID: 4040470
    [Abstract] [Full Text] [Related]

  • 11. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
    Näbauer M, Böhm M, Brown L, Diet F, Eichhorn M, Kemkes B, Pieske B, Erdmann E.
    Eur J Clin Invest; 1988 Dec 19; 18(6):600-6. PubMed ID: 2465159
    [Abstract] [Full Text] [Related]

  • 12. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.
    Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB.
    N Engl J Med; 1982 Jul 22; 307(4):205-11. PubMed ID: 6283349
    [Abstract] [Full Text] [Related]

  • 13. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
    Robberecht P, De Neef P, Waelbroeck M, Camus JC, Fontaine J, Christophe J.
    Pflugers Arch; 1984 May 22; 401(1):1-5. PubMed ID: 6540864
    [Abstract] [Full Text] [Related]

  • 14. The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
    Hussain RI, Aronsen JM, Afzal F, Sjaastad I, Osnes JB, Skomedal T, Levy FO, Krobert KA.
    J Mol Cell Cardiol; 2013 Mar 22; 56():129-38. PubMed ID: 23220156
    [Abstract] [Full Text] [Related]

  • 15. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A, MacLeod KM.
    J Pharmacol Exp Ther; 1993 Sep 22; 266(3):1594-601. PubMed ID: 7690405
    [Abstract] [Full Text] [Related]

  • 16. Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure.
    Reithmann C, Werdan K.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep 22; 339(1-2):138-44. PubMed ID: 2471084
    [Abstract] [Full Text] [Related]

  • 17. Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice.
    Uhl S, Mathar I, Vennekens R, Freichel M.
    J Mol Cell Cardiol; 2014 Sep 22; 74():307-17. PubMed ID: 24972051
    [Abstract] [Full Text] [Related]

  • 18. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties.
    de Souza NJ, Dohadwalla AN, Reden J.
    Med Res Rev; 1983 Sep 22; 3(2):201-19. PubMed ID: 6345959
    [No Abstract] [Full Text] [Related]

  • 19. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
    Sjaastad I, Schiander I, Sjetnan A, Qvigstad E, Bøkenes J, Sandnes D, Osnes JB, Sejersted OM, Skomedal T.
    Acta Physiol Scand; 2003 Apr 22; 177(4):449-58. PubMed ID: 12648162
    [Abstract] [Full Text] [Related]

  • 20. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.
    Tanaka H, Shigenobu K.
    Br J Pharmacol; 1990 May 22; 100(1):138-42. PubMed ID: 2164856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.